← Return to After breast cancer: 12 years out, questions about recurrence

Discussion

After breast cancer: 12 years out, questions about recurrence

Breast Cancer | Last Active: Jul 1, 2022 | Replies (79)
Comment receiving replies
@callalloo

The OncotypeDX is solely designed to help the client evaluate the risk/reward payoff of chemo given that persons unique genetics. Oncotype is adamant that it does not help with a decision as to radiation. They do not currently offer any tests addressing the benefit of radiation with respect to a radiation decision.

Jump to this post

Replies to "The OncotypeDX is solely designed to help the client evaluate the risk/reward payoff of chemo given..."
monigue | @monigue | Mar 26, 2022

Thank you
I would like to think that while our discussion with the surgeon the risk of having chemo and/or rad was greater, than don’t .
Honestly, I haven’t heard from the doctor strait forward explanation/ advice and came to the conclusion myself ( NO)
based on my present AFIB ( arrhythmia ) and age factor !!
If the heart isn’t strong enough, thinking😇 about cancer reoccurrence should come second !

VIEW AND REPLY